Kleinostheim, March 1, 2007 – Today, curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard, has placed 525,000 new ordinary shares, in the form of bearer shares, as a capital increase against cash. This capital increase was submitted to the Supervisory Board February 28 for approval and authorization on March 1. The capital increase of EUR 525,000, from currently EUR 6,250,000 to EUR 6,775,000, was executed within the framework of existing Authorised Capital (so-called “Genehmigtes Kapital”).

The shares offered in this private placement round were subscribed by institutional investors. The subscription right of shareholders does not apply. The issue price of the new shares is EUR 2.41 per share. The new shares have a dividend right, effective January 1, 2007.

The proceeds from this offering will primarily be used for financing a complementary product line of biological materials.